Literature DB >> 9401486

Steroid therapy for paralytic deformities in leprosy.

D S Sugumaran1.   

Abstract

One-hundred-forty-nine patients with 272 nerve paralyses, with visible deformity and gross disability, were prospectively followed up with steroid therapy. Out of 151 ulnar paralyses, 101 recovered (67%). Out of 52 median nerve paralyses, 45 recovered (86%); out of 69 foot drops, 54 recovered (78%) for an overall improvement of 73%. Serious side effects were few. Hence, steroid therapy should be widely encouraged for the treatment of early nerve damage to prevent permanent deformity/disability, and vigilance in spotting complications of steroid therapy is emphasized.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9401486

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  3 in total

1.  Effects of prednisolone treatment on cytokine expression in patients with leprosy type 1 reactions.

Authors:  Anna K Andersson; MeherVani Chaduvula; Sara E Atkinson; Saroj Khanolkar-Young; Suman Jain; Lavanya Suneetha; Sujai Suneetha; Diana N J Lockwood
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Coinfection of leprosy and tuberculosis.

Authors:  Seema Shetty; Shashikiran Umakanth; Bhawani Manandhar; Pankaj Bahadur Nepali
Journal:  BMJ Case Rep       Date:  2018-03-15

3.  Peripheral Neuropathy Due to Leprosy.

Authors:  Sharon P. Nations; Richard J. Barohn
Journal:  Curr Treat Options Neurol       Date:  2002-05       Impact factor: 3.972

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.